Your HRV Is Low Despite Training Hard. Here's Why.

Your blood vessels produce nitric oxide (NO) to relax and dilate. This is the biological foundation of healthy HRV. When blood vessels dilate smoothly, your heart can modulate its rate with precision. Nitric oxide is produced by an enzyme called endothelial nitric oxide synthase, encoded by the NOS3 gene.

The NOS3 Glu298Asp variant, carried by roughly 30-40% of people, produces less functional nitric oxide synthase. That means your endothelial cells are making less NO, your blood vessels dilate less efficiently, and your HRV is chronically dampened because your cardiovascular system cannot respond dynamically to autonomic signals.

You experience this as a sluggish heart rate response to training, a high baseline resting heart rate that doesn’t drop with relaxation, and poor exercise recovery. Your heart feels tethered. You can push hard in a workout, but your heart rate stays elevated for hours afterward, and your HRV during sleep never recovers fully.

The renin-angiotensin system is your body’s master controller of blood pressure and vascular tone. It works by producing a hormone called angiotensin II, which makes blood vessels contract and raises blood pressure. The ACE gene encodes the enzyme that produces angiotensin II. The more ACE activity you have, the more angiotensin II your system makes, and the more rigid your blood pressure becomes.

The ACE I/D polymorphism controls how much of this enzyme you produce. People with the D/D genotype, roughly 25% of the population, have two copies of the D allele. D/D carriers produce significantly more ACE, leading to chronically elevated angiotensin II, higher baseline blood pressure, and more rigid blood vessel tone. Your cardiovascular system operates in a state of permanent contraction.

For HRV, this means your blood pressure regulation becomes inflexible. Your heart rate doesn’t modulate smoothly because the underlying vascular tone is locked tight. Your HRV is low because angiotensin II keeps your sympathetic nervous system in a state of mild activation. You feel chronically “on” even at rest.

The methylation cycle is the cellular process that clears stress hormones like epinephrine, norepinephrine, and dopamine from your system after activation. It also produces the cofactors needed to synthesize neurotransmitters. MTHFR catalyzes a critical early step in this cycle: converting dietary folate into the active form your cells can use. If MTHFR is impaired, your methylation cycle slows, and stress hormones accumulate.

The MTHFR C677T variant, carried by roughly 40% of Europeans, reduces enzyme efficiency by 40-70%. That means your cells are extracting usable folate from your diet at a fraction of the rate they should be. Stress hormones like epinephrine and norepinephrine, which your heart produces during sympathetic activation, clear much more slowly from your system. You can take a breath and calm down consciously, but the biochemistry is still flooded.

For HRV, this manifests as difficulty recovering from stress or training. Your heart rate stays elevated, your breathing stays shallow, and your HRV recovery from exercise takes twice as long. You feel wired even hours after stress. Your nervous system cannot reset because the catecholamines are still present.

COMT is the primary enzyme that breaks down and clears dopamine, norepinephrine, and epinephrine once your autonomic nervous system has deployed them. After a stressful event or intense training, COMT is supposed to deactivate these stress hormones and restore calm. The gene has a common variant called Val158Met that slows COMT activity dramatically.

People who are homozygous for the Met allele (slow COMT), roughly 25% of Europeans, have only 25-40% of the COMT enzyme activity of people with the Val/Val genotype. Stress hormones linger in your bloodstream far longer than they should, keeping your sympathetic nervous system chronically activated and your HRV suppressed.

You experience this as difficulty relaxing after stress, persistent anxiety, hypervigilance, and a racing baseline heart rate. Your HRV is low because your system never fully parasympathetically tone back down. Even during sleep, your breathing is slightly shallow and your heart rate doesn’t drop as much as it should. Caffeine is devastating: it increases dopamine and norepinephrine release, and your slow COMT cannot clear it, so you stay wired for 12-18 hours after a cup of coffee.

Your heart beats because ions like sodium, potassium, and calcium flow in and out of cardiac cells in a precisely timed sequence. This electrical dance is controlled by ion channels, protein pores in the cell membrane that open and close to let ions through. SCN5A encodes the primary sodium channel in your heart. If it’s impaired, the electrical impulses that coordinate your heartbeat become unstable.

SCN5A variants can reduce sodium channel function and are associated with arrhythmia syndromes. Roughly 1-2% of the population carries a pathogenic SCN5A variant; many more carry minor variants that reduce channel efficiency without causing clinical arrhythmia. Even subclinical reductions in sodium channel function reduce the electrical stability of your heartbeat, leading to lower HRV and increased ectopic beats.

You may not feel anything obvious. Your ECG is normal. But your HRV is lower than expected, you have occasional extra heartbeats, and your heart rate variability from breath to breath is reduced. Your heart’s rhythm is less fluid, less able to respond fluidly to changes in breathing or autonomic tone.

After your heart’s electrical signal fires and the ventricles contract, the cardiac cells must repolarize (restore their negative charge) so they can fire again. This repolarization is controlled by potassium channels that allow potassium ions to flow out of the cell. KCNQ1 encodes one of these critical channels. If KCNQ1 is impaired, repolarization is delayed, and your heart’s electrical recovery becomes sluggish.

KCNQ1 variants are associated with Long QT syndrome, a condition where the QT interval (the time between electrical activation and recovery) is abnormally prolonged. Pathogenic variants are rare, but minor variations in KCNQ1 function are more common. People with reduced KCNQ1 function have slightly prolonged QT intervals and reduced HRV because their cardiac cells take longer to electrically reset between beats. The rhythm is constrained.

You experience this as a feeling that your heart rate doesn’t vary smoothly, that your heartbeats feel slightly irregular or stiff, and that your HRV is chronically suppressed despite good training and recovery habits. You may also notice your heart rate increases more than expected with gentle exertion, because the delayed repolarization reduces the heart’s ability to increase its rate dynamically.